+1K Reviews

Tirzepatide

Lose weight with tirzepatide, an FDA compliant compounded version of the same active ingredient in Mounjaro® and Zepbound™. Tirzepatide, is a dual GLP-1, GIP RA recognized for effective weight loss.*
Starting at
$449
$399/mo
Shop nowSee if I'm eligible
Important safety information
Compounded tirzepatide has not been approved by the FDA. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. 


Tirzepatide, an FDA compliant compounded version of the same active ingredient in Mounjaro and Zepbound™, is a dual GLP-1/GIP RA recognized for effective weight loss. Compounded tirzepatide is adapted to individual needs and offers a highly effective approach to weight loss and glycemic control.*

It targets brain centers to reduce hunger, enhancing feelings of fullness. This GLP-1 receptor agonist, mirroring natural body processes, effectively regulates blood sugar and supports weight loss.

Why Bioverse customers

love Tirzepatide

Maria, 38
Real Bioverse Customer
Tirzepatide has surpassed my expectations. It’s not just weight loss; I feel more energetic and in tune with my body’s needs.
Aisha, 29
Real Bioverse Customer
Honestly, SO happy that I started with tirzepatide. The weight has been coming off, and I’m experiencing fewer blood sugar spikes.
David, 41
Real Bioverse Customer
Tirzepatide has changed my diabetes and weight control. It’s been easier to manage my diet and exercise plan with its support.

Why you'll love

weight loss by Bioverse

Personalized to you
Custom plan. Expert support. Easy adjustments.
Best value for GLP-1
Starts at $399/month. Lower than 12 leading brands.*
Quick results
Lose an average of 10 lbs in 30 days.†
Find my treatment
*Comparison based on 12-mo. plan prices for compounded tirzepatide from 12 leading competitors as of December 2024.

†From a self-reported Bioverse survey of 407 patients who started customized weight loss treatment. Results may vary.

How It

Works

Tell us about you
Custom plan. Expert support. Easy adjustments.
Get Evaluated
A licensed provider reviews your info and, if appropriate, prescribes a treatment.
Personalized to you
Custom plan. Expert support. Easy adjustments.
Start your free assessment

Frequently Asked

Questions

Explore common questions about Compounded Tirzepatide.
See if treatment is right for me

Popular, doctor-trusted treatments

Semaglutide

Lose weight with Semaglutide, the same active ingredient in Ozempic® and Wegovy®

NAD+ Injection

Improve cell energy production, mental clarity, and mood with NAD+ injections

B12 Injection

Improve cognitive function and metabolic health with methylcobalamin B12

Glutathione Injection

Boost immune system & increase energy levels with glutathione injections

Disclaimers

* Bioverse offers compounded drug products, including semaglutide and tirzepatide, which are not FDA-approved. Compounded drug products, including semaglutide and tirzepatide, are not approved or evaluated for safety, effectiveness, or quality by the FDA. These products are compounded in accordance with applicable laws and are to be used only as prescribed by a licensed healthcare provider.

* Any references to active ingredients such as semaglutide and tirzepatide being similar to those in FDA-approved products like Ozempic, Wegovy, Mounjaro, or Zepbound are intended solely to provide information about the active ingredients and are not intended to imply that our compounded products are equivalent to or interchangeable with these FDA-approved products.

* Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide), and Generic Liraglutide are not compounded. Ozempic®, Mounjaro®, and Generic Liraglutide are FDA-approved for type 2 diabetes treatment but may also be prescribed for weight loss at a healthcare provider’s discretion. Wegovy® and Zepbound® are FDA-approved for weight loss.

* Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Bioverse is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.